SAM
UTHR icon

Smartleaf Asset Management’s United Therapeutics UTHR Stock Holding History

Smartleaf Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186K Hold
341
– – 0.01% 858
2026
Q1 		$201K Buy
341
+11
+3% +$5.48K 0.01% 784
2025
Q4 		$164K Buy
330
+77
+30% +$35.9K 0.01% 900
2025
Q3 		$107K Buy
253
+112
+79% +$37.7K 0.01% 1030
2025
Q2 		$40.1K Sell
141
-59
-30% -$17.6K ﹤0.01% 1258
2025
Q1 		$61.4K Hold
200
– – 0.01% 1050
2024
Q4 		$71.5K Hold
200
– – 0.01% 1008
2024
Q3 		$71.7K Buy
200
+183
+1,076% +$61.8K 0.01% 802
2024
Q2 		$5.39K Buy
17
+7
+70% +$1.85K ﹤0.01% 1764
2024
Q1 		$2.43K Buy
10
+9
+900% +$2.03K ﹤0.01% 1429
2023
Q4 		$0 Buy
+1
New +$230 ﹤0.01% 1237

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Smartleaf Asset Management's UTHR Position: Q2 2026 in Review

Smartleaf Asset Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 341 shares worth $186K. The position accounts for 0.01% of the portfolio, ranked #858.

Smartleaf Asset Management first reported a position in UTHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $201K in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Smartleaf Asset Management held 341 shares of United Therapeutics worth $186K as of Q2 2026.
  • Smartleaf Asset Management left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #858 holding.
  • Smartleaf Asset Management first reported a position in United Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's United Therapeutics position peaked at $201K in Q1 2026.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.